• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points.

作者信息

Wang Gui-Qiang, Zhao Lei, Wang Xia, Jiao Yan-Mei, Wang Fu-Sheng

机构信息

Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing 100034, China.

Medical Department of Infectious Diseases, Fifth Medical Center of PLA General Hospital, Beijing 100039, China.

出版信息

Infect Dis Immun. 2021 Apr 20;1(1):17-19. doi: 10.1097/ID9.0000000000000002. eCollection 2021 Apr.

DOI:10.1097/ID9.0000000000000002
PMID:38630067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057309/
Abstract
摘要

相似文献

1
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points.《新型冠状病毒肺炎诊疗方案（试行第八版）》解读：更新要点阐释
Infect Dis Immun. 2021 Apr 20;1(1):17-19. doi: 10.1097/ID9.0000000000000002. eCollection 2021 Apr.
2
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition).新型冠状病毒肺炎诊疗方案（试行第八版）
Infect Dis Immun. 2021 Apr 20;1(1):8-16. doi: 10.1097/01.ID9.0000733564.21786.b0. eCollection 2021 Apr.
3
Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors.第八版美国癌症联合委员会（AJCC）胆囊癌分期系统的验证：预后判别及关键预测因素的识别
Cancers (Basel). 2021 Feb 1;13(3):547. doi: 10.3390/cancers13030547.
4
Need to restage Korean melanoma patients following publication of the 8th edition of the American Joint Committee on Cancer staging manual.需要重新分期韩国黑色素瘤患者，以适应第 8 版美国癌症联合委员会分期手册的出版。
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):332-336. doi: 10.25259/IJDVL_680_20.
5
A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.第 7 版和第 8 版 AJCC 分期系统在预测甲状腺乳头状癌患者复发和生存方面的比较。
Oral Oncol. 2018 Dec;87:158-164. doi: 10.1016/j.oraloncology.2018.11.003. Epub 2018 Nov 9.
6
Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.AJCC 第 8 版分期系统对接受手术联合放疗的日本乳腺癌患者的预后价值。
Int J Clin Oncol. 2020 Aug;25(8):1499-1505. doi: 10.1007/s10147-020-01686-x. Epub 2020 Apr 30.
7
Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.根据第 8 版美国癌症联合委员会分期标准对 pT1 黑色素瘤进行改良分层：一项荷兰基于人群的研究。
Eur J Cancer. 2018 Mar;92:100-107. doi: 10.1016/j.ejca.2017.10.031. Epub 2017 Dec 5.
8
A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.将 pT4aN0M0 纳入 IIIA 期，为第 8 版 AJCC 胃癌分期系统提供更好的预后分层。
Surg Oncol. 2019 Jun;29:90-96. doi: 10.1016/j.suronc.2019.03.005. Epub 2019 Apr 1.
9
Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.评估 1008 例接受根治性切除术的肝细胞癌患者的美国癌症联合委员会（AJCC）第 8 版分期系统。
Cancer Res Treat. 2020 Oct;52(4):1145-1152. doi: 10.4143/crt.2020.208. Epub 2020 Apr 28.
10
Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual.第 8 版与第 7 版美国癌症联合委员会癌症分期手册中眼睑癌 T 分类的变化。
Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):38-41. doi: 10.1097/IOP.0000000000001133.

引用本文的文献

1
The prognostic value of serum apolipoprotein A1 levels in elderly patients with SARS-CoV-2 omicron infection.血清载脂蛋白A1水平在老年SARS-CoV-2奥密克戎感染患者中的预后价值
Front Cell Infect Microbiol. 2025 Jul 30;15:1617266. doi: 10.3389/fcimb.2025.1617266. eCollection 2025.
2
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.摩洛哥重症 COVID-19 ICU 患者中 TYK2、IFITM3、IFNAR2 和 OAS3 单核苷酸多态性。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241257241. doi: 10.1177/03946320241257241.
3
Genetic clues to COVID-19 severity: exploring the stromal cell-derived factor-1/CXCL12 rs2839693 polymorphism in adult Egyptians.遗传线索与 COVID-19 严重程度：探索成年埃及人基质细胞衍生因子-1/CXCL12 rs2839693 多态性。
BMC Infect Dis. 2023 Oct 19;23(1):702. doi: 10.1186/s12879-023-08691-1.
4
Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery.线粒体功能障碍、脂质代谢和氨基酸生物合成是新冠病毒疾病康复的关键途径。
iScience. 2023 Sep 19;26(10):107948. doi: 10.1016/j.isci.2023.107948. eCollection 2023 Oct 20.
5
Prolonged Viral Shedding in Three Young Adult Cases of COVID-19.三例年轻成人新冠病毒病患者的病毒长期脱落情况
Infect Dis Immun. 2022 Oct;2(4):289-292. doi: 10.1097/ID9.0000000000000041. Epub 2022 Aug 12.
6
Elevated serum beta-2 microglobulin level predicts short-term poor prognosis of patients with acute omicron variant COVID-19 infection.血清β-2 微球蛋白水平升高可预测急性奥密克戎变异株 COVID-19 感染患者短期预后不良。
Front Cell Infect Microbiol. 2023 Jul 13;13:1204326. doi: 10.3389/fcimb.2023.1204326. eCollection 2023.
7
Fucosylated N-glycans as early biomarkers of COVID-19 severity.糖基化 N-聚糖可作为 COVID-19 严重程度的早期生物标志物。
Front Immunol. 2023 Jun 5;14:1204661. doi: 10.3389/fimmu.2023.1204661. eCollection 2023.
8
Ct, polymorphism, and laboratory biomarkers for predicting chemosensory dysfunctions and mortality in COVID-19.用于预测COVID-19患者化学感觉功能障碍和死亡率的CT、多态性及实验室生物标志物
Future Sci OA. 2023 Mar 9;9(2):FSO838. doi: 10.2144/fsoa-2022-0082. eCollection 2023 Feb.
9
Hematological, Inflammatory, Coagulation, and Oxidative/Antioxidant Biomarkers as Predictors for Severity and Mortality in COVID-19: A Prospective Cohort-Study.血液学、炎症、凝血及氧化/抗氧化生物标志物作为COVID-19严重程度和死亡率的预测指标：一项前瞻性队列研究
Int J Gen Med. 2023 Feb 17;16:565-580. doi: 10.2147/IJGM.S402206. eCollection 2023.
10
Relationship between initial symptoms and the prognosis, sex, and demographic area of patients with COVID-19.新型冠状病毒肺炎患者初始症状与预后、性别及人口统计学地区之间的关系。
Front Med (Lausanne). 2022 Dec 14;9:1040062. doi: 10.3389/fmed.2022.1040062. eCollection 2022.

本文引用的文献

1
Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition).新型冠状病毒肺炎诊疗方案（试行第八版）
Infect Dis Immun. 2021 Apr 20;1(1):8-16. doi: 10.1097/01.ID9.0000733564.21786.b0. eCollection 2021 Apr.
2
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study.中国 COVID-19 合并脑卒中患者的临床特征和治疗结局：一项多中心回顾性研究。
Phytomedicine. 2021 Jan;81:153433. doi: 10.1016/j.phymed.2020.153433. Epub 2020 Dec 4.
3
COVID-19 in China: Risk Factors and R Revisited.中国的 COVID-19：危险因素和 R 再探讨。
Acta Trop. 2021 Jan;213:105731. doi: 10.1016/j.actatropica.2020.105731. Epub 2020 Oct 22.
4
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.中国武汉 COVID-19 幸存者的临床后遗症：一项单中心纵向研究。
Clin Microbiol Infect. 2021 Jan;27(1):89-95. doi: 10.1016/j.cmi.2020.09.023. Epub 2020 Sep 23.
5
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.在 COVID-19 大流行期间提供药学服务的建议和指导：中国视角。
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824. doi: 10.1016/j.sapharm.2020.03.012. Epub 2020 Mar 26.